Development of an ANN optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain
References
- 1. N. Salamat-Miller, M. Chittchang and T. P. Johnston, The use of mucoadhesive polymers in buccal drug delivery,(2005) 1666–1691; DOI: 10.1016/j.addr.2005.07.003.
- 2. R. A. Medve, J. Wang and R. Karim, Tramadol and acetaminophen tablets for dental pain,(2001) 79–81.
- 3. B. W. Morrison, S. Christensen, W. Yuan, J. Brown, S. Amlani and B. Seidenberg, Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial,(1999) 943–953; DOI: 10.1016/S0149-2918(99)80016-2.
- 4. J. M. Swegle and C. Logemann, Management of common opioid-induced adverse effects,(2006) 1347–1354.
- 5. I. Bjarnason, J. Hayllar, A. J. Macpherson and A. Russell, Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans,(1993) 1832–1847.
- 6. A. Sultan, H. J. McQuay, R. A. Moore and S. Derry, Single dose oral flurbiprofen for acute postoperative pain in adults,(2009); DOI: 10.1002/14651858.CD007358.
- 7. M. Takada, M. Fukusaki, Y. Terao, K. Yamashita, C. Inadomi, M. Takada and K. Sumikawa, Preadministration of flurbiprofen suppresses prostaglandin production and postoperative pain in orthopedic patients undergoing tourniquet inflation,(2007) 97–100; DOI: 10.1016/j.jclinane.2006.05.028.
- 8. R. K. Flath, M. L. Hicks, R. A. Dionne and G. B. Pelleu Jr., Pain suppression after pulpectomy with preoperative flurbiprofen,(1987) 339–347; DOI: 10.1016/S0099-2399(87)80116-487.
- 9. Y. Fujii and Y. Shiga, Flurbiprofen axetil preceded by venous occlusion in the prevention of pain on propofol injection in the hand: a prospective, randomized, double-blind, vehicle-controlled, dose-finding study in Japanese adult surgical patients,(2005) 588–593; 10.1016/j.clinthera.2005.05.003.
- 10. P.-L. Lin, S.-Z. Fan, C.-H. Huang, H.-H. Huang, M.-C. Tsai, C.-J. Lin and W.-Z. Sun, Analgesic effect of lidocaine patch 5 % in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study,(2008) 320–325.
- 11. L. Perioli, V. Ambrogi, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen,(2007) E20-E27; DOI: 10.1208/pt0803054.
- 12. H. Okamoto, H. Taguchi, K. Iida and K. Danjo, Development of polymer film dosage forms of lidocaine for buccal administration: I. Penetration rate and release rate,(2001) 253–260; DOI: 10.1016/s0168-3659(01)00509-001.
- 13. Y. Sudhakar, K. Kuotsu and A. Bandyopadhyay, Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs,(2006) 15–40; 10.1016/j.jconrel.2006.04.012.
- 14. V. F. Patel, F. Liu and M. B. Brown, Advances in oral transmucosal drug delivery,(2011) 106–116; DOI: 10.1016/j.jconrel.2011.01.027.
- 15. A. Bernkop-Schnürch and S. Steininger, Synthesis and characterisation of mucoadhesive thiolated polymers,(2000) 239–247; 10.1016/s0378-5173(99)00387-799.
- 16. I. Knight, The development and applications of sucralose, a new high-intensity sweetener,(1994) 435–439; DOI: 10.1139/y94-063.
- 17. L. Allen, Featured excipient: capsule and tablet diluents,(2000) 306–312.
- 18. V. M. Patel, B. G. Prajapati, H. V. Patel and K. M. Patel, Mucoadhesive bilayer tablets of propranolol hydrochloride,.(2007) E203-E208; 10.1208/pt0803077.
- 19. L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease,(2004) 521–533; DOI: 10.1016/j.jconrel.2003.12.018.
- 20. S. Mohammadi-Samani, R. Bahri-Najafi and G. Yousefi, Formulation and in vitro evaluation of prednisolone buccoadhesive tablets,(2005) 339–344; DOI: 10.1016/j.farmac.2005.01.009.
- 21. S. Edavalath and B. Rao, Design, development and optimization of buccal bioadhesive tablets of diclofenac sodium for the treatment of odontalgia,(2011) 5–13.
- 22. M. S. PendekalP. K. Tegginamat, Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine,(2012) 318–324; DOI: 10.1016/j.apsb.2011.12.012.
- 23. N. Shah, G. Zhang, V. Apelian, F. Zeng, M. H. Infeld and A. W. Malick, Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: effect of polymer concentration,(1993) 1693–1695; DOI: 10.1023/a:1018901509855.
- 24. J. Malakar, A. K. Nayak and S. Goswami, Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release,(2012), article ID 730624; DOI: 10.5402/2012/730624.
- 25. S. Dash, P. N. Murthy, L. Nath and P. Chowdhury, Kinetic modeling on drug release from controlled drug delivery systems,(2010) 217–223; DOI: 10.1080/10717540490265379.
- 26. D. Jones,, Smithers Rapra Publishing, U.K. 2004. pp. 31–35.
- 27. J. Parojčić, Z. Ðurić, M. Jovanović and S. Ibrić, An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers,(2004) 59–65.
- 28. X. Huang and C. S. Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems,(2001) 121–136; DOI: 10.1016/s0168-3659(01)00248-601.
Language: English
Page range: 245 - 256
Accepted on: Dec 21, 2015
Published on: May 28, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2016 Amjad Hussain, Muhammad Ali Syed, Nasir Abbas, Sana Hanif, Muhammad Sohail Arshad, Nadeem Irfan Bukhari, Khalid Hussain, Muhammad Akhlaq, Zeeshan Ahmad, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.